Seraxis
Our Technology
Seraxis technology replaces the islets that are missing in people who suffer from Type 1 Diabetes
We manufacture pancreatic endocrine cell clusters to replace the native pancreatic cells that are responsible for regulating blood glucose.
These cells secrete precise amounts of insulin, glucagon and other hormones to maintain the right amount of fuel for the body’s energy needs.
Seraxis pancreatic endocrine cells are different:
We manufacture from a proprietary stem cell line that was engineered from a donor’s pancreatic islet
The result is a pure, potent and safe cell replacement therapy
The Seraxis endocrine cells have a highly compatible genetic profile for allogeneic transplant recipients
We have also modified this line to enable future implant to patients without anti-rejection therapy
The Seraxis team has established an endocrine cell manufacturing process that is 21 CFR part 210 and 211 compliant.
